The TNFalpha locus is altered in monocytes from patients with systemic lupus erythematosus

In systemic lupus erythematosus, TNFalpha is elevated in the serum and correlates with disease activity and triglyceride levels. The stimuli that drive TNFalpha in this setting are incompletely understood. This study was designed to evaluate monocyte chromatin at the TNFalpha locus to identify semi-...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Clinical immunology (Orlando, Fla.). - 1999. - 123(2007), 1 vom: 20. Apr., Seite 74-81
1. Verfasser: Sullivan, Kathleen E (VerfasserIn)
Weitere Verfasser: Suriano, April, Dietzmann, Kelly, Lin, Janice, Goldman, Daniel, Petri, Michelle A
Format: Aufsatz
Sprache:English
Veröffentlicht: 2007
Zugriff auf das übergeordnete Werk:Clinical immunology (Orlando, Fla.)
Schlagworte:Journal Article Research Support, N.I.H., Extramural Histones Lipopolysaccharide Receptors Tumor Necrosis Factor-alpha
LEADER 01000naa a22002652 4500
001 NLM168189879
003 DE-627
005 20231223114558.0
007 tu
008 231223s2007 xx ||||| 00| ||eng c
028 5 2 |a pubmed24n0561.xml 
035 |a (DE-627)NLM168189879 
035 |a (NLM)17276734 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Sullivan, Kathleen E  |e verfasserin  |4 aut 
245 1 4 |a The TNFalpha locus is altered in monocytes from patients with systemic lupus erythematosus 
264 1 |c 2007 
336 |a Text  |b txt  |2 rdacontent 
337 |a ohne Hilfsmittel zu benutzen  |b n  |2 rdamedia 
338 |a Band  |b nc  |2 rdacarrier 
500 |a Date Completed 04.05.2007 
500 |a Date Revised 13.11.2018 
500 |a published: Print-Electronic 
500 |a Citation Status MEDLINE 
520 |a In systemic lupus erythematosus, TNFalpha is elevated in the serum and correlates with disease activity and triglyceride levels. The stimuli that drive TNFalpha in this setting are incompletely understood. This study was designed to evaluate monocyte chromatin at the TNFalpha locus to identify semi-permanent changes that might play a role in altered expression of TNFalpha. SLE patients with relatively quiescent disease (mean Physician Global Assessment=0.6) and healthy controls were recruited for this study. TNFalpha expression was measured by intracellular cytokine staining of different monocyte subsets in patients (n=24) and controls (n=12). Histone acetylation at the TNFalpha locus was measured by chromatin immunoprecipitation using a normalized quantitative PCR in patients (n=46) and controls (n=24). There were no differences in the overall fractions of cells expressing CD14 in SLE patients compared to controls; however, the fraction of DR+/CD16+ cells expressing CD14 was slightly higher as was true in the monocyte subset defined by DR+/CD11b+. Within the monocyte population defined by physical characteristics and DR+/CD14+, TNFalpha expressing cells were more frequent in SLE patients compared to controls. Both the fraction of positive cells and the mean fluorescence intensity were higher in patients than controls. Consistent with this was the finding that monocytes from patients had increased TNFalpha transcripts and more highly acetylated histones at the TNFalpha locus compared to controls. Furthermore, patients with the highest levels of TNFalpha histone acetylation were more likely to have had consistently elevated erythrocyte sedimentation rates, and to have required cytotoxic use. Histone acetylation, associated with increased transcriptional competence of TNFalpha, may play a role in certain inflammatory aspects of the disease 
650 4 |a Journal Article 
650 4 |a Research Support, N.I.H., Extramural 
650 7 |a Histones  |2 NLM 
650 7 |a Lipopolysaccharide Receptors  |2 NLM 
650 7 |a Tumor Necrosis Factor-alpha  |2 NLM 
700 1 |a Suriano, April  |e verfasserin  |4 aut 
700 1 |a Dietzmann, Kelly  |e verfasserin  |4 aut 
700 1 |a Lin, Janice  |e verfasserin  |4 aut 
700 1 |a Goldman, Daniel  |e verfasserin  |4 aut 
700 1 |a Petri, Michelle A  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Clinical immunology (Orlando, Fla.)  |d 1999  |g 123(2007), 1 vom: 20. Apr., Seite 74-81  |w (DE-627)NLM098196855  |x 1521-7035  |7 nnns 
773 1 8 |g volume:123  |g year:2007  |g number:1  |g day:20  |g month:04  |g pages:74-81 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_11 
912 |a GBV_ILN_24 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 123  |j 2007  |e 1  |b 20  |c 04  |h 74-81